Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-12

Clinical Trial Update: Bioequivalence Study to Compare Fluticasone Furoate (FF) 1-strip Inhaler With FF 2-strip Inhaler and With FF/Vilanterol Combination [Phase 1]

View source ↗

Summary

A Phase 1 bioequivalence study comparing Fluticasone Furoate 1-strip inhaler to a 2-strip inhaler and to the Fluticasone Furoate/Vilanterol combination in asthm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone Furoate (fluticasone furoate)
  • Fluticasone Furoate/Vilanterol (fluticasone furoate/vilanterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED